Expanding Therapeutic Areas Brill Pharma's current focus on dermatology and ophthalmology presents opportunities to introduce complementary medicines or diagnostic products targeting these specialized markets, especially as the company plans to expand into new therapeutic areas with high added value.

International Market Growth With ambitions to enter other Ibero-American markets, there is potential to develop localized sales channels, partnerships, and distribution agreements to facilitate rapid market penetration and increase regional revenue streams.

Research Collaboration Brill Pharma's commitment to supporting medical research projects creates opportunities to offer specialized clinical trial services, research tools, or co-developer solutions to pharmaceutical and healthcare organizations seeking to innovate in dermatology and ophthalmology.

Partnership Expansion Existing collaborations with firms like Girona FC and Alimera Sciences demonstrate an openness to strategic partnerships, providing a pathway to introduce new products, enhance brand visibility, and secure multi-year distribution or licensing agreements.

Technology and Digital Engagement The company's use of advanced tech stacks suggests a readiness to adopt digital marketing, telemedicine solutions, or electronic health record integrations, which could open sales opportunities in digital health tools or patient engagement platforms tailored to healthcare providers.